Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
A randomized phase II trial of a new...
Journal article

A randomized phase II trial of a new anticoagulant, apixaban, in metastatic cancer

Abstract

e20514

Authors

Levine MN; Deitchman D; Julian J; Liebman H; Escalante C; O'Brien MC; Ramirez L; Weise-Kelly L; Solymoss S

Journal

Journal of Clinical Oncology, Vol. 27, No. 15_suppl, pp. e20514–e20514

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

May 20, 2009

DOI

10.1200/jco.2009.27.15_suppl.e20514

ISSN

0732-183X